HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Photobleaching kinetics of optically trapped multilamellar vesicles containing verteporfin using two-photon excitation section sign.

Abstract
Two-photon excitation photodynamic therapy (TPE-PDT) is being developed as an improved treatment for retinal diseases. TPE-PDT has advantages over one-photon PDT, including lower collateral damage to healthy tissue and more precise delivery of PDT. As with one-photon PDT, there can be local photochemical depletion of oxygen during TPE-PDT. Here, we investigate model systems and live cells to measure local photosensitizer photobleaching and through it, infer local oxygen consumption in therapeutic volumes of the order 1 microm3. Multilamellar vesicles (MLV) and African green monkey kidney (CV-1) cells were used to study the TPE photobleaching dynamics of the photosensitizer, Verteporfin. It was found that in an oxygen-rich environment, photobleaching kinetics could not be modeled using a mono-exponential function, whereas in hypoxic conditions a mono-exponential decay was adequate to represent photobleaching. A biexponential was found to adequately model the oxygen-rich conditions and it is hypothesized that the fast part of the decay is oxygen-dependent, whereas the slower rate constant is largely oxygen-independent. Photobleaching recovery studies in the CV-1 cells support this hypothesis.
AuthorsKimberley S Samkoe, Matthew S Fecica, Rebecca L Goyan, Jennifer L Buchholz, Chantel Campbell, Nicole M Kelly, David T Cramb
JournalPhotochemistry and photobiology (Photochem Photobiol) 2006 Jan-Feb Vol. 82 Issue 1 Pg. 152-7 ISSN: 0031-8655 [Print] United States
PMID16149861 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Liposomes
  • Porphyrins
  • Verteporfin
  • Oxygen
Topics
  • Humans
  • Kinetics
  • Liposomes
  • Oxygen
  • Photochemotherapy
  • Photons
  • Porphyrins (chemistry)
  • Retinal Diseases (therapy)
  • Verteporfin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: